CSIMarket


Anavex Life Sciences Corp   (AVXL)
Other Ticker:  
 

Anavex Life Sciences Corp

AVXL's Fundamental analysis








Anavex Life Sciences 's sales fell in II. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -0.98 %

Anavex Life Sciences net loss deacreased by in II. Quarter 2024 year on year, Anavex Life Sciences net loss increased by -19.54 % in II. Quarter 2024 year on year,

More on AVXL's Growth


Anavex Life Sciences
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Anavex Life Sciences PEG ratio is at -0.11 Anavex Life Sciences realized cash outflow of $ -0.17per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
19.38
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 183.73.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.7.


More on AVXL's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.64

Anavex Life Sciences
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Anavex Life Sciences PEG ratio is at -0.11 Anavex Life Sciences realized cash outflow of $ -0.17per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
19.38
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 183.73.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.7.

Anavex Life Sciences Price to Book Ratio is at 2.49 lower than Indusry Avg. of 757.55. and higher than S&P 500 Avg. of 0.01

More on AVXL's Valuation

  Market Capitalization (Millions $) 336
  Shares Outstanding (Millions) 82
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -41
  Cash Flow (TTM) (Millions $) -14
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 1.64

  Market Capitalization (Millions $) 336
  Shares Outstanding (Millions) 82
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -41
  Cash Flow (TTM) (Millions $) -14
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 16.72
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.13
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com